These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20845989)

  • 21. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
    Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
    Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
    Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
    J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure.
    Schoket B; Papp G; Lévay K; Mracková G; Kadlubar FF; Vincze I
    Mutat Res; 2001 Oct; 482(1-2):57-69. PubMed ID: 11535249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer.
    Sørensen M; Autrup H; Tjønneland A; Overvad K; Raaschou-Nielsen O
    Int J Cancer; 2004 Jun; 110(2):219-24. PubMed ID: 15069685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of glutathione S-transferase P1 polymorphisms (Ile105Val and Ala114Val) in patients with small cell lung cancer.
    Vural B; Yakar F; Derin D; Saip P; Yakar A; Demirkan A; Karabulut A; Ugurel E; Cine N; Kilicaslan Z; Tüzün E; Ozbek U
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):701-6. PubMed ID: 22339038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.
    R Yang X; Pfeiffer RM; Goldstein AM
    J Med Genet; 2006 Apr; 43(4):e16. PubMed ID: 16582078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.
    Lecomte T; Landi B; Beaune P; Laurent-Puig P; Loriot MA
    Clin Cancer Res; 2006 May; 12(10):3050-6. PubMed ID: 16707601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
    Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
    Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of xenobiotic metabolizing genes in head and neck cancer tissues.
    Masood N; Malik FA; Kayani MA
    Asian Pac J Cancer Prev; 2011; 12(2):377-82. PubMed ID: 21545198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Wu G; Jiang B; Liu X; Shen Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
    Yang M; Choi Y; Hwangbo B; Lee JS
    Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil.
    Abnet CC; Fagundes RB; Strickland PT; Kamangar F; Roth MJ; Taylor PR; Dawsey SM
    Carcinogenesis; 2007 Jan; 28(1):112-7. PubMed ID: 16864595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer.
    Dialyna IA; Arvanitis DA; Spandidos DA
    Int J Mol Med; 2001 Jul; 8(1):79-87. PubMed ID: 11408954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer.
    Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Biomarkers; 2008 May; 13(3):282-95. PubMed ID: 18415801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.